Autoimmune Disease Diagnosis Market Growth Analysis | 2023-2028

Market Insights

The autoimmune disease diagnosis market was estimated at USD 5.14 billion in 2022 and is likely to grow at a CAGR of 8.84% during 2023-2028 to reach USD 8.57 billion in 2028.

Wish to get a free sample? Click Here.

What is an autoimmune disease diagnosis?

Autoimmune diseases are diseases where the immune system (which protects the body from bacteria and viruses) mistakenly attacks the healthy cells of the body. There are over 80 types with similar symptoms, and their prevalence is increasing worldwide, affecting an estimated 8% of the population. Factors such as lifestyle changes, environmental factors, and genetic predispositions contribute to this increase. Autoimmune disease diagnosis involves identifying and confirming the presence of an autoimmune disease, which can affect any part of the body. The symptoms of autoimmune diseases can be varied and nonspecific, making diagnosis difficult. However, early diagnosis is crucial for improving patient outcomes, allowing for earlier intervention and treatment, which can help prevent or delay disease progression and manage symptoms more effectively.

Market Dynamics

With increasing autoimmune diseases among the growing elderly population and mounting awareness about these diseases, development in R&D is expected to drive the global autoimmune disease diagnosis market during the forecast period. Advancements in diagnostic technology have led to more accurate, sensitive, and specific tests that can detect autoimmune diseases earlier, improving patient outcomes. The growing public and healthcare professionals' awareness of autoimmune diseases is also driving increased demand for testing and diagnosis.

Challenges:

Challenges in diagnosis: Autoimmune diseases, characterized by their diverse and nonspecific symptoms, can be challenging to diagnose and treat, potentially leading to delayed diagnosis and worsened patient outcomes. Insufficiency of specific biomarkers: The absence of precise biomarkers for numerous autoimmune diseases makes it challenging to create accurate and dependable diagnostic tests.

Opportunities:

Surge in prevalence of autoimmune diseases: The global increase in autoimmune diseases is leading to a surge in the demand for diagnostic tests. Development in diagnostic technology: Recent developments in diagnostic technology for autoimmune diseases have led to the development of more accurate, sensitive, and specific tests. Increasing awareness of autoimmune diseases: The increasing public and healthcare professionals' awareness of autoimmune diseases is leading to a surge in demand for testing and diagnosis.

Want to have a closer look at this report? Get a Free Sample.

Segments Analysis

By Product Type

The market is segmented into consumables & assay kits and instruments. Consumables & assay kits are expected to remain the dominant segment during the forecast period. Their higher sensitivity as compared to conventional test kits gives accurate results even with smaller samples. In addition, development in biotechnology and cost-effectiveness of consumables & assay kits, owing to the reduced need for secondary verification, are expected to propel the growth of the segment during the forecast period.

By Test Type

The market is segmented as routine laboratory tests, inflammatory markers, autoantibodies & immunologic tests, and other tests. Autoantibodies & immunologic tests are expected to remain the dominant segment during the forecast period.

By Disease Type

The market is segmented as rheumatoid arthritis, systemic lupus erythematosus, Sjogren’s syndrome, thyroiditis, scleroderma, and other diseases. The rheumatoid arthritis segment is expected to command the market during the forecast period. It is the most common disease that affects the wrist and hand joints among the elderly population.

By End-User Type

The market is segmented into clinical laboratories, hospitals, and others. Clinical laboratories are expected to dominate the market during the forecast period. Clinical laboratories’ tests are performed to aid the diagnosis of autoimmune disorders, which usually include blood test autoantibodies as well as inflammations such as CRP and ECR.

Regional Insights

Europe is estimated to remain the largest market during the forecast period due to the rising chronic diseases such as rheumatoid arthritis among the increasing ageing population. Autoimmune diseases affect 5-10% of the population in Europe and North America. The 3TR project (taxonomy, treatments, targets and remission) funded by the EU’s Innovative Medicines Initiative with €80 million for the next seven years to discover biomarkers that can predict which patients will respond best to the treatments for autoimmune diseases is another significant factor contributing to the growth of the region’s autoimmune disease diagnosis market.

To know which region offers the best growth opportunities, Register Here

Critical Questions Answered in the Report

• What are the key trends in the global market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on the global market?
• What are the key strategies adopted by the major vendors to lead in the market?
• What is the market share of the top vendors?

Market Segmentation

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The autoimmune disease diagnosis market is segmented into the following categories.

By Product Type

• Consumables & Assay Kits
• Instruments

By Test Type

• Routine Laboratory Tests
• Inflammatory Markers
• Autoantibodies & Immunologic Tests
• Other Tests

By Disease Type

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Sjogren’s Syndrome
• Scleroderma
• Thyroiditis
• Other Diseases

By End-User Type

• Clinical Laboratories
• Hospitals
• Others

By Region

• North America (Country Analysis: the USA, Canada, and Mexico)
• Europe (Country Analysis: Germany, France, the UK, Russia, and Rest of Europe)
• Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Click Here, to learn the market segmentation details.

Key Players

Some of the major players in the market are-

• Abbott Laboratories
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Euroimmun AG
• Grifols S.A.
• Hycor Biomedical Inc.
• Siemens AG
• Thermo Fisher Scientific
• Trinity Biotech plc
• Werfen
• others

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the global autoimmune disease diagnosis market.

What Deliverables Will You Get in this Report?

Report Customization Options

Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players).
• SWOT analysis of key players (up to 3 players).

Segmentation

• Current market segmentation of any one of the disease types by end-user type.

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.